Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells? | Front Oncol | 2020 | 32351895 | PubTator, text mining | PubMed |
| Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer. | Cancer Med | 2020 | 32351019 | PubTator, text mining | PubMed |
| Tumor Plasticity and Resistance to Immunotherapy. | Trends Cancer | 2020 | 32348738 | PubTator, text mining | PubMed |
| The area between ROC curves, a non-parametric method to evaluate a biomarker for patient treatment selection. | Biom J | 2020 | 32346912 | PubTator, text mining | PubMed |
| The duality of human oncoproteins: drivers of cancer and congenital disorders. | Nat Rev Cancer | 2020 | 32341551 | PubTator, text mining | PubMed |
| The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study. | Endocrine | 2020 | 32333269 | PubTator, text mining | PubMed |
| Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration. | PLoS One | 2020 | 32330138 | PubTator, text mining | PubMed |
| Next-Generation Sequencing-Based Cancer Panel Data Conversion Using International Standards to Implement a Clinical Next-Generation Sequencing Research System: Single-Institution Study. | JMIR Med Inform | 2020 | 32329738 | PubTator, text mining | PubMed |
| Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer. | Cell Death Dis | 2020 | 32312965 | PubTator, text mining | PubMed |
| TNF-Signaling Modulates Neutrophil-Mediated Immunity at the Feto-Maternal Interface During LPS-Induced Intrauterine Inflammation. | Front Immunol | 2020 | 32308656 | PubTator, text mining | PubMed |
| Immunotherapy Combined with Chemotherapy as a Promising Therapy for a EGFR Exon 19 Deletion with MET Amplification Patient with Non-Small-Cell Lung Cancer: A Case Report. | Onco Targets Ther | 2020 | 32308434 | PubTator, text mining | PubMed |
| AR-dependent phosphorylation and phospho-proteome targets in prostate cancer. | Endocr Relat Cancer | 2020 | 32276264 | PubTator, text mining | PubMed |
| Genetic Characterization of Molecular Targets in Korean Patients with Gastrointestinal Stromal Tumors. | J Gastric Cancer | 2020 | 32269842 | PubTator, text mining | PubMed |
| Multiplexed molecular profiling of lung cancer with malignant pleural effusion using next generation sequencing in Chinese patients. | Oncol Lett | 2020 | 32269623 | PubTator, text mining | PubMed |
| The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study. | Oncol Lett | 2020 | 32269612 | PubTator, text mining | PubMed |
| Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material. | BMC Cancer | 2020 | 32264863 | PubTator, text mining | PubMed |
| Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade. | Int J Mol Sci | 2020 | 32260561 | PubTator, text mining | PubMed |
| Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies. | Front Cell Dev Biol | 2020 | 32258034 | PubTator, text mining | PubMed |
| Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis. | Semin Liver Dis | 2020 | 32242330 | PubTator, text mining | PubMed |
| COVID-19: a new challenge for human beings. | Cell Mol Immunol | 2020 | 32235915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=63